Literature DB >> 28932573

Donors after cardiocirculatory death and lung transplantation.

Ilhan Inci1.   

Abstract

The number of patients actively awaiting lung transplantation (LTx) is more than the number of suitable donor lungs. The percentage of lung retrieval rate is lower when compared to other solid organs. The use of lungs from donation after cardiocirculatory death (DCD) donors is one of the options to avoid organ shortage in LTx. After extensive experimental research, clinical application of DCD donation is becoming wider. The results from most of the centers show at least equal survival rate compared to donors from brain death. This review paper will summarize experimental background and clinical experience from DCD donors.

Entities:  

Keywords:  Donation after cardiocirculatory death (DCD); lung; lung transplantation (LTx); survival

Year:  2017        PMID: 28932573      PMCID: PMC5594200          DOI: 10.21037/jtd.2017.07.82

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  68 in total

Review 1.  Non-heart-beating donors in thoracic transplantation.

Authors:  Thomas M Egan
Journal:  J Heart Lung Transplant       Date:  2004-01       Impact factor: 10.247

2.  Surfactant alterations following donation after cardiac death donor lungs.

Authors:  Ilhan Inci; Stephan Arni; Christa Acevedo; Wolfgang Jungraithmayr; Demet Inci; Peter Vogt; Walter Weder
Journal:  Transpl Int       Date:  2010-08-16       Impact factor: 3.782

3.  Normothermic ex vivo lung perfusion in clinical lung transplantation.

Authors:  Marcelo Cypel; Jonathan C Yeung; Mingyao Liu; Masaki Anraku; Fengshi Chen; Wojtek Karolak; Masaaki Sato; Jane Laratta; Sassan Azad; Mindy Madonik; Chung-Wai Chow; Cecilia Chaparro; Michael Hutcheon; Lianne G Singer; Arthur S Slutsky; Kazuhiro Yasufuku; Marc de Perrot; Andrew F Pierre; Thomas K Waddell; Shaf Keshavjee
Journal:  N Engl J Med       Date:  2011-04-14       Impact factor: 91.245

4.  Ex vivo lung evaluation of prearrest heparinization in donation after cardiac death.

Authors:  Pablo G Sanchez; Gregory J Bittle; Katrina Williams; Chetan Pasrija; Kai Xu; Xufeng Wei; Zhongjun J Wu; Bartley P Griffith
Journal:  Ann Surg       Date:  2013-03       Impact factor: 12.969

5.  Excellent clinical outcomes from a national donation-after-determination-of-cardiac-death lung transplant collaborative.

Authors:  B J Levvey; M Harkess; P Hopkins; D Chambers; C Merry; A R Glanville; G I Snell
Journal:  Am J Transplant       Date:  2012-07-23       Impact factor: 8.086

6.  Lungs from donation after circulatory death donors: an alternative source to brain-dead donors? Midterm results at a single institution.

Authors:  Bartlomiej Zych; Aron-Frederik Popov; Mohamed Amrani; Toufan Bahrami; Karen Christina Redmond; Heike Krueger; Martin Carby; André Ruediger Simon
Journal:  Eur J Cardiothorac Surg       Date:  2012-02-26       Impact factor: 4.191

Review 7.  New classification of donation after circulatory death donors definitions and terminology.

Authors:  Marie Thuong; Angel Ruiz; Patrick Evrard; Michael Kuiper; Catherine Boffa; Mohammed Z Akhtar; James Neuberger; Rutger Ploeg
Journal:  Transpl Int       Date:  2016-05-04       Impact factor: 3.782

Review 8.  Update on donor assessment, resuscitation, and acceptance criteria, including novel techniques--non-heart-beating donor lung retrieval and ex vivo donor lung perfusion.

Authors:  Jonathan C Yeung; Marcelo Cypel; Thomas K Waddell; Dirk van Raemdonck; Shaf Keshavjee
Journal:  Thorac Surg Clin       Date:  2009-05       Impact factor: 1.750

9.  Unilateral lung transplantation for pulmonary fibrosis.

Authors: 
Journal:  N Engl J Med       Date:  1986-05-01       Impact factor: 91.245

10.  When does the lung die? Time course of high energy phosphate depletion and relationship to lung viability after "death".

Authors:  A M D'Armini; E J Tom; C S Roberts; D C Henke; J J Lemasters; T M Egan
Journal:  J Surg Res       Date:  1995-10       Impact factor: 2.192

View more
  7 in total

Review 1.  Organ donation after circulatory death: current status and future potential.

Authors:  Martin Smith; B Dominguez-Gil; D M Greer; A R Manara; M J Souter
Journal:  Intensive Care Med       Date:  2019-02-06       Impact factor: 17.440

Review 2.  Organ procurement in a deceased donor.

Authors:  Hong Pil Hwang; Jong Man Kim; Sung Shin; Hyung Joon Ahn; Sik Lee; Dong Jin Joo; Seung Yeup Han; Seok Jin Haam; Jeong Kye Hwang; Hee Chul Yu
Journal:  Korean J Transplant       Date:  2020-09-30

3.  The Future Direction of the Organ Donation System After Legislation of the Life-Sustaining Treatment Decision Act.

Authors:  Seung Min Baik; Jin Park; Tae Yoon Kim; Jung Hwa Lee; Kyung Sook Hong
Journal:  Ann Transplant       Date:  2021-11-23       Impact factor: 1.530

Review 4.  Minimizing Ischemia Reperfusion Injury in Xenotransplantation.

Authors:  Parth M Patel; Margaret R Connolly; Taylor M Coe; Anthony Calhoun; Franziska Pollok; James F Markmann; Lars Burdorf; Agnes Azimzadeh; Joren C Madsen; Richard N Pierson
Journal:  Front Immunol       Date:  2021-09-09       Impact factor: 7.561

5.  Trends in Donation After Circulatory Death in Lung Transplantation in the United States: Impact Of Era.

Authors:  Christopher M Bobba; Bryan A Whitson; Matthew C Henn; Nahush A Mokadam; Brian C Keller; Justin Rosenheck; Asvin M Ganapathi
Journal:  Transpl Int       Date:  2022-04-04       Impact factor: 3.842

6.  Functional, Metabolic and Morphologic Results of Ex Vivo Donor Lung Perfusion with a Perfluorocarbon-Based Oxygen Carrier Nanoemulsion in a Large Animal Transplantation Model.

Authors:  Ilhan Inci; Stephan Arni; Ilker Iskender; Necati Citak; Josep Monné Rodriguez; Miriam Weisskopf; Isabelle Opitz; Walter Weder; Thomas Frauenfelder; Marie Pierre Krafft; Donat R Spahn
Journal:  Cells       Date:  2020-11-18       Impact factor: 6.600

7.  Subnormothermic ex vivo lung perfusion attenuates ischemia reperfusion injury from donation after circulatory death donors.

Authors:  Stephan Arni; Tatsuo Maeyashiki; Isabelle Opitz; Ilhan Inci
Journal:  PLoS One       Date:  2021-08-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.